Found 1 Presentation For Request "LBA8"

Proffered Paper session Proffered Paper session

LBA8_PR - KEYNOTE-522: Phase 3 study of pembrolizumab (pembro) + chemotherapy (chemo) vs placebo (pbo) + chemo as neoadjuvant treatment, followed by pembro vs pbo as adjuvant treatment for early triple-negative breast cancer (TNBC) (ID 1812)

Presentation Number
LBA8_PR
Lecture Time
17:15 - 17:30
Speakers
  • Peter Schmid (London, United Kingdom)
Location
Barcelona Auditorium (Hall 2), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
16:30 - 18:00